pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
2,804
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
fluvoxamine maleate
Luvox (fluvoxamine maleate)
Obsessive-Compulsive Disorder
$ANIP
ANI PHARMACEUTICALS INC
Marketed
fluvoxamine maleate ER
Fluvoxamine Maleate
Obsessive-Compulsive Disorder
Par Pharmaceutical Inc
Marketed
follitropin alfa
Gonal-F (follitropin alfa)
Anovulation
EMD Serono Inc
Marketed
← prev
page 67 of 94
next →
131
Pain
89
Neurology
1
fomepizole
Fomepizole
Ethylene Glycol or Methanol Poisoning
Navinta LLC
Marketed
fondaparinux sodium
Fondaparinux Sodium
Deep Vein Thrombosis (DVT)
ScinoPharm Taiwan Ltd
Marketed
formoterol fumarate
Perforomist (formoterol fumarate)
Chronic Bronchitis
Mylan Specialty LP
Marketed
fosamprenavir calcium
Fosamprenavir Calcium
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Mylan Pharmaceuticals Inc
Marketed
fosaprepitant dimeglumine
Fosaprepitant Dimeglumine
Chemotherapy Induced Nausea and Vomiting
Athenex Inc (Inactive)
Marketed
foscarnet sodium
Foscarnet Sodium
Cytomegalovirus (CMV) Retinitis
Sciecure Pharma Inc
Marketed
fosdenopterin hydrobromide
Nulibry (fosdenopterin hydrobromide)
Molybdenum Cofactor Deficiency Type A (MOCODA)
Sentynl Therapeutics Inc
Marketed
fosinopril sodium
Fosinopril Sodium
Congestive Heart Failure (Heart Failure)
InvaGen Pharmaceuticals Inc
Marketed
fosphenytoin sodium
Fosphenytoin Sodium
Status Epilepticus
Wockhardt USA LLC
Marketed
fostamatinib disodium
Tavalisse (fostamatinib disodium)
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytope…
$RIGL
RIGEL PHARMACEUTICALS INC
Marketed
fostemsavir tromethamine ER
Rukobia (fostemsavir tromethamine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ViiV Healthcare Company
Marketed
fremanezumab
Ajovy (fremanezumab-vfrm)
Migraine
Teva Pharmaceuticals USA Inc
Marketed
frovatriptan succinate
Frovatriptan Succinate
Migraine
Renata PLC
Marketed
gabapentin enacarbil ER
Horizant (gabapentin enacarbil)
Postherpetic Neuralgia
Azurity Pharmaceuticals Inc
Marketed
galantamine hydrobromide
Galantamine Hydrobromide
Dementia Associated With Alzheimer's Disease
Slate Run Pharmaceuticals LLC
Marketed
galantamine hydrobromide ER
Galantamine Hydrobromide
Dementia Associated With Alzheimer's Disease
Sun Pharmaceutical Industries Ltd
Marketed
galcanezumab
Emgality (galcanezumab-gnlm)
Migraine
Eli Lilly and Co
Marketed
galsulfase
Naglazyme (galsulfase)
Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome )
$BMRN
BIOMARIN PHARMACEUTICAL INC
Marketed
ganciclovir sodium
Ganciclovir Sodium
Cytomegalovirus (CMV) Retinitis
Slate Run Pharmaceuticals LLC
Marketed
ganirelix acetate
Ganirelix Acetate
Ovarian Hyperstimulation Syndrome
Ferring Pharmaceuticals Inc
Marketed
garadacimab
Andembry (garadacimab [INN])
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
CSL Behring LLC
Marketed
gatifloxacin
Zymaxid (gatifloxacin)
Bacterial Conjunctivitis
$ABBV
AbbVie Inc.
Marketed
gefitinib
Gefitinib
Non-Small Cell Lung Cancer
Actavis Laboratories NY Inc (Inactive)
Marketed
gemfibrozil
Gemfibrozil
Hyperlipidemia
Nivagen Pharmaceuticals Inc
Marketed
gemtuzumab ozogamicin
Mylotarg (gemtuzumab ozogamicin)
Refractory Acute Myeloid Leukemia
$PFE
PFIZER INC
Marketed
gentamicin sulfate
Gentamicin Sulfate
Bacterial Blepharoconjunctivitis
Fera Pharmaceuticals LLC
Marketed
gepirone hydrochloride ER
Exxua (gepirone hydrochloride)
Major Depressive Disorder
Fabre-Kramer Pharmaceuticals Inc
